U.S. Akoya Biosciences, Boston Beer Company, Victory Capital Holdings
May 14 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Akoya Biosciences, Boston Beer Company and Victory Capital Holdings on Tuesday.
HIGHLIGHTS
* Akoya Biosciences Inc AKYA.O: Canaccord Genuity cuts target price to $6 from $10 |
* Boston Beer Company Inc SAM.N: Jefferies raises target price to $360 from $335 |
* Fortrea Holdings Inc FTRE.O: Evercore ISI cuts target price to $31 from $43 |
* Medical Properties Trust Inc MPW.N: RBC cuts to sector perform from outperform |
* Victory Capital Holdings Inc VCTR.O: RBC raises target price to $56 from $47 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* AAR Corp AIR.N: Stifel raises target price to $86 from $81 |
* Acrivon Therapeutics Inc ACRV.O: H.C. Wainwright raises target price to $22 from $20 |
* Actinium Pharmaceuticals Inc ATNM.A: Stephens initiates coverage with overweight rating |
* Actinium Pharmaceuticals Inc ATNM.A: Stephens initiates coverage with price target $25 |
* Advanced Micro Devices Inc AMD.O: Evercore ISI cuts target price to $193 from $200 |
* Agilon Health Inc AGL.N: Jefferies cuts target price to $5.75 from $6.5 |
* Agilysys Inc AGYS.O: Northland Capital raises target price to $118 from $105 |
* Agilysys Inc AGYS.O: Oppenheimer raises target price to $100 from $95 |
* Airsculpt Technologies Inc AIRS.O: Leerink Partners cuts target price to $5.00 from $8.25 |
* Airsculpt Technologies Inc AIRS.O: Leerink Partners cuts to market perform from outperform |
* Akoya Biosciences Inc AKYA.O: BTIG cuts target price to $6 from $9 |
* Akoya Biosciences Inc AKYA.O: Canaccord Genuity cuts target price to $6 from $10 |
* Akoya Biosciences Inc AKYA.O: JP Morgan cuts target price to $7 from $10 |
* Allogene Therapeutics Inc ALLO.O: B. Riley cuts target price to $7 from $10 |
* Allogene Therapeutics Inc ALLO.O: Stifel raises target price to $4.6 from $4.4 |
* Alta Equipment Group Inc ALTG.N: Raymond James cuts target price to $14 from $19.5 |
* Ameresco Inc AMRC.N: UBS raises target price to $39 from $36 |
* American Eagle Outfitters Inc AEO.N: TD Cowen raises target price to $25 from $23 |
* American Electric Power Company Inc AEP.O: BMO raises target price to $99 from $95 |
* Amicus Therapeutics Inc FOLD.O: Guggenheim raises to buy from neutral |
* Amylyx Pharmaceuticals Inc AMLX.O: Mizuho cuts target price to $3 from $4 |
* Angel Oak Mortgage REIT Inc AOMR.N: UBS raises target price to $10.5 from $10 |
* Antero Resources Corp AR.N: BMO raises target price to $35 from $30 |
* APA Corporation APA.O: BMO cuts target price to $35 from $40 |
* Applied DNA Sciences Inc APDN.O: Maxim Group cuts to hold from buy |
* Arcellx Inc ACLX.O: Evercore ISI initiates coverage with outperform rating; PT $85 |
* Aris Water Solutions Inc ARIS.N: Evercore ISI raises target price to $20 from $16 |
* Atlanticus Holdings Corp ATLC.O: Jefferies cuts target price to $40 from $50 |
* Atmos Energy ATO.N: Barclays raises target price to $129 from $121 |
* Atmos Energy ATO.N: Wells Fargo raises target price to $132 from $130 |
* Atmos Energy ATO.N: Wells Fargo raises to overweight from equal-weight |
* Avalonbay Communities Inc AVB.N: Scotiabank raises target price to $213 from $193 |
* Avalonbay Communities Inc AVB.N: UBS raises target price to $210 from $199 |
* Baker Hughes Co BKR.O: BMO cuts target price to $38 from $40 |
* Baldwin Insurance Group Inc BRP.O: UBS raises target price to $37 from $35 |
* Banc of California Inc BANC.N: Stephens cuts target price to $15 from $16 |
* Berry Corporation (Bry) BRY.O: BMO cuts target price to $8 from $9 |
* Biomarin Pharmaceutical BMRN.O: Evercore ISI initiates with outperform rating; PT $113 |
* Blue Owl Capital Corp OBDC.N: KBW cuts to market perform from outperform |
* Blue Owl Capital Inc OWL.N: Citigroup resumes coverage with buy rating; target price $21 |
* Blueprint Medicines Corp BPMC.O: Stephens initiates coverage with overweight rating; price target $140 |
* Booz Allen Hamilton Holding Corp BAH.N: Jefferies raises target price to $180 from $170 |
* Boston Beer Company Inc SAM.N: Jefferies raises target price to $360 from $335 |
* Boston Beer Company Inc SAM.N: Jefferies raises to buy from hold |
* Bridgebio Pharma BBIO.O: Evercore ISI initiates coverage with outperform rating; PT $50 |
* Brighthouse Financial Inc BHF.O: KBW cuts target price to $48 from $50 |
* Broadstone Net Lease Inc BNL.N: Truist Securities cuts target price to $16 from $17 |
* Camden Property Trust CPT.N: Scotiabank raises target price to $108 from $104 |
* Camden Property Trust CPT.N: UBS raises target price to $109 from $105 |
* Caredx Inc CDNA.O: Raymond James cuts to market perform from outperform |
* Caretrust REIT Inc CTRE.N: Jefferies raises target price to $28 from $27 |
* Carnival Corp CCL.N: UBS raises target price to $21 from $20 |
* Celanese Corp CE.N: BMO raises target price to $158 from $153 |
* Centuri Holdings CTRI.N: Siebert Williams initiates coverage with buy rating; PT $32 |
* Century Therapeutics Inc IPSC.O: Guggenheim cuts target price to $12 from $14 |
* Chesapeake Energy Corp CHK.O: BMO raises target price to $95 from $93 |
* Chesapeake Utilities Corp CPK.N: RBC raises target price to $125 from $124 |
* Chevron Corp CVX.N: BMO raises target price to $175 from $170 |
* Chuy's Holdings Inc CHUY.O: Stifel cuts target price to $32 from $36 |
* Civista Bancshares Inc CIVB.O: D.A. Davidson cuts target price by $4 to $17 |
* Clearway Energy Inc CWENa.N: Evercore ISI raises target price to $30 from $25 |
* Clearway Energy Inc CWENa.N: RBC raises target price to $26 from $25 |
* Clearway Energy Inc CWENa.N: UBS raises target price to $33 from $32 |
* CMS Energy Corp CMS.N: BMO raises target price to $71 from $68 |
* CNX Resources Corp CNX.N: BMO cuts target price to $24 from $25 |
* Compass Inc COMP.N: Deutsche Bank raises target price to $4 from $3.8 |
* Compass Inc COMP.N: UBS raises target price to $4 from $3.5 |
* Compass Therapeutics Inc. CMPX.O: Jefferies cuts target price to $7 from $8 |
* Compass Therapeutics Inc. CMPX.O: Leerink Partners cuts target price to $10 from $11 |
* Conocophillips COP.N: BMO cuts target price to $135 from $140 |
* Conocophillips COP.N: RBC raises target price to $140 from $135 |
* Constellation Brands Inc STZ.N: Jefferies cuts target price to $311 from $314 |
* Constellation Energy Corp CEG.O: RBC raises target price to $218 from $211 |
* CubeSmart CUBE.N: Truist Securities cuts target price to $44 from $46 |
* Cummins Inc CMI.N: Bernstein raises target price to $321 from $297 |
* CVR Energy Inc CVI.N: UBS cuts target price to $33.75 from $37 |
* Definitive Healthcare Corp DH.O: Jefferies cuts target price to $10 from $12 |
* Delcath Systems Inc DCTH.O: Stephens initiates coverage with overweight rating; price target $25 |
* Deluxe Corp DLX.N: TD Cowen raises target price to $35 from $33 |
* Diamondback Energy Inc FANG.O: BMO cuts target price to $210 from $213 |
* Dril-Quip Inc DRQ.N: Barclays cuts target price to $21 from $22 |
* Edison International EIX.N: Wells Fargo raises target price to $86 from $72 |
* Edison International EIX.N: Wells Fargo raises to overweight from equal-weight |
* Edwards Lifesciences Corp EW.N: Deutsche Bank raises target price to $103 from $86 |
* Edwards Lifesciences Corp EW.N: Deutsche Bank raises to buy from hold |
* Elevation Oncology Inc ELEV.O: Stephens initiates with overweight rating; PT $8 |
* Emerson EMR.N: Berenberg raises target price to $133 from $130 |
* Enhabit Inc EHAB.N: Leerink Partners raises to market perform from underperform |
* EOG Resources Inc EOG.N: BMO cuts target price to $140 from $145 |
* Epam Systems Inc EPAM.N: Mizuho cuts target price to $258 from $345 |
* EPR Properties EPR.N: Truist Securities cuts target price to $44 from $46 |
* Equity Residential EQR.N: Scotiabank raises target price to $72 from $65 |
* Equity Residential EQR.N: UBS raises target price to $75 from $73 |
* Essex Property Trust Inc ESS.N: Scotiabank raises target price to $283 from $256 |
* Essex Property Trust Inc ESS.N: UBS raises target price to $261 from $250 |
* Evergy Inc EVRG.O: Barclays raises target price to $61 from $56 |
* Evolent Health Inc EVH.N: Truist Securities cuts target price to $28 from $34 |
* Exelixis Inc EXEL.O: Stephens initiates coverage with equal-weight rating; PT $23 |
* Expro Group Holdings NV XPRO.N: Barclays raises to overweight from equal-weight; raises PT to $27 from $18 |
* Five Below Inc FIVE.O: Jefferies cuts target price to $200 from $215 |
* Fluence Energy Inc FLNC.O: RBC cuts target price to $29 from $33 |
* Fortrea Holdings Inc FTRE.O: Evercore ISI cuts target price to $31 from $43 |
* Freeport-Mcmoran Inc FCX.N: UBS raises target price to $54 from $41 |
* Fulcrum Therapeutics Inc FULC.O: Leerink Partners raises target price to $16 from $14 |
* Fulcrum Therapeutics Inc FULC.O: Oppenheimer cuts target price to $14 from $16 |
* Gap Inc GPS.N: TD Cowen raises target price to $24 from $21 |
* Global Net Lease Inc GNL.N: Truist Securities raises target price to $8 from $7 |
* Green Plains Inc GPRE.O: Jefferies cuts target price to $37 from $45 |
* Hess Corp HES.N: BMO raises target price to $175 from $165 |
* HF Sinclair Corp DINO.N: BMO cuts target price to $70 from $77 |
* Houlihan Lokey Inc HLI.N: UBS cuts target price to $145 from $157 |
* Hudson Pacific Properties Inc HPP.N: Jefferies cuts target price to $8 from $10 |
* IAC Inc IAC.O: Wells Fargo raises target price to $84 from $82 |
* Inotiv Inc NOTV.O: Jefferies cuts target price to $3.75 from $11.5 |
* Inotiv Inc NOTV.O: Jefferies cuts to hold from buy |
* Inovio Pharmaceuticals Inc INO.O: Stephens initiates coverage with overweight rating; price target $20 |
* Installed Building Products Inc IBP.N: Benchmark raises target price to $270 from $250 |
* Intuit Inc INTU.O: Morgan Stanley raises target price to $740 |
* Iovance Biotherapeutics Inc IOVA.O: Truist Securities cuts PT to $25 from $26 |
* Jackson Financial Inc JXN.N: KBW cuts to market perform from outperform |
* Jackson Financial Inc JXN.N: KBW raises target price to $80 from $75 |
* Jeld-Wen Holding Inc JELD.N: Jefferies cuts target price to $16 from $20 |
* KBR Inc KBR.N: UBS raises target price to $77 from $68 |
* Lear Corp LEA.N: BofA Global Research cuts price objective to $205 from $210 |
* Legend Biotech Corp LEGN.O: Jefferies raises target price to $94 from $93 |
* Legend Biotech Corp LEGN.O: RBC raises target price to $86 from $85 |
* Legend Biotech Corporation LEGN.O: H.C. Wainwright cuts target price to $86 from $87 |
* Liberty Media Corp FWONK.O: Rosenblatt Securities raises target price to $89 from $88 |
* Live Oak Bancshares Inc LOB.N: Truist Securities raises target price to $40 from $38 |
* Luxurban Hotels Inc LUXH.O: Jonestrading cuts to hold rating |
* Madison Square Garden Entertainment Corp MSGE.N: Macquarie raises PT to $46 from $45 |
* Magna International Inc MGA.N: BofA Global Research cuts price objective to $65 from $70 |
* Marathon Oil Corp MRO.N: BMO cuts target price to $30 from $32 |
* Marathon Petroleum Corp MPC.N: BMO cuts target price to $215 from $235 |
* Markel Group Inc MKL.N: Citigroup raises target price to $1435 from $1375 |
* Matador Resources Co MTDR.N: BMO cuts target price to $79 from $80 |
* Medical Properties Trust Inc MPW.N: RBC cuts to sector perform from outperform |
* Mid-America Apartment Communities Inc MAA.N: Scotiabank raises target price to $144 from $139 |
* Mid-America Apartment Communities Inc MAA.N: UBS raises PT to $131 from $126 |
* Moderna MRNA.O: Evercore ISI initiates coverage with in line rating; price target $120 |
* Morgan Stanley Direct Lending Fund MSDL.N: Wells Fargo cuts target price to $21 from $22 |
* Murphy Oil Corp MUR.N: BMO cuts target price to $50 from $55 |
* National Health Investors Inc NHI.N: Jefferies raises target price to $63 from $54 |
* Nelnet Inc NNI.N: TD Cowen raises target price to $96 from $90 |
* Neurocrine Biosciences NBIX.O: Evercore ISI initiates with outperform rating; PT $175 |
* Neurogene Inc NGNE.O: Leerink Partners cuts target price to $45 from $46 |
* Neuronetics Inc STIM.O: William Blair raises to outperform rating |
* Nisource Inc NI.N: Barclays raises target price to $31 from $30 |
* Northwest Natural Holding Co NWN.N: RBC cuts target price to $41 from $45 |
* Nov Inc NOV.N: BMO raises target price to $22 from $21 |
* Novabay Pharmaceuticals Inc NBY.A: Ascendiant Capital Markets cuts PT to $1.75 from $2 |
* Nurix Therapeutics Inc NRIX.O: Stephens initiates coverage with overweight rating; price target $20 |
* Nvidia Corp NVDA.O: Wells Fargo raises target price to $1150 from $970 |
* Oceaneering International OII.N: Barclays cuts target price to $21 from $22 |
* Oceaneering International OII.N: Barclays cuts to underweight from equal-weight |
* Opendoor Technologies Inc OPEN.O: UBS cuts target price to $2.75 from $3 |
* Orange County Bancorp Inc OBT.O: Stephens cuts target price to $53 from $56 |
* Orion Group Holdings Inc ORN.N: Craig-Hallum initiates coverage with buy rating and target price $14 |
* Ormat Technologies Inc ORA.N: UBS raises target price to $100 from $95 |
* Ovintiv Inc OVV.N: BMO cuts target price to $61 from $63 |
* Palo Alto Networks Inc PANW.O: Evercore ISI adds stock to its tactical underperform list |
* Palo Alto Networks Inc PANW.O: Evercore ISI cuts target price to $385 from $405 |
* PBF Energy Inc PBF.N: BMO cuts target price to $65 from $69 |
* Peakstone Realty Trust PKST.N: Truist Securities raises target price to $16 from $15 |
* Penske Automotive Group Inc PAG.N: BofA Global Research cuts price objective to $175 from $180 |
* Permian Resources Corp PR.N: BMO cuts target price to $21 from $22 |
* Permian Resources Corp PR.N: RBC raises target price to $20 from $17 |
* Perpetua Resources Corp PPTA.O: H.C. Wainwright raises target price to $13.25 from $10.5 |
* Perspective Therapeutics CATX.A: RBC initiates coverage With Outperform rating; PT $3 |
* Phillips 66 PSX.N: BMO cuts target price to $170 from $185 |
* Plains All American Pipeline LP PAA.O: RBC raises target price to $18 from $17 |
* Planet Fitness Inc PLNT.N: JP Morgan raises target price to $78 from $68 |
* Planet Fitness Inc PLNT.N: JP Morgan raises to overweight from neutral |
* Prime Medicine Inc PRME.O: Guggenheim cuts target price to $18 from $20 |
* Primerica Inc PRI.N: KBW cuts target price to $255 from $260 |
* Public Storage PSA.N: Truist Securities cuts target price to $306 from $315 |
* R1 RCM Inc RCM.O: Deutsche Bank cuts target price to $14 from $15 |
* Regeneron Pharmaceuticals REGN.O: Evercore ISI initiates coverage with outperform rating |
* Regeneron Pharmaceuticals REGN.O: Evercore ISI initiates coverage with PT $1150 |
* Roblox Corp RBLX.N: Roth MKM cuts target price to $35 from $55 |
* Roblox Corp RBLX.N: Roth MKM cuts to neutral from buy |
* Royal Caribbean Cruises Ltd RCL.N: UBS raises target price to $168 from $154 |
* Sarepta Therapeutics Inc SRPT.O: Oppenheimer raises to outperform from perform |
* Sensei Biotherapeutics SNSE.O: Stephens initiates with overweight rating and $5 price target |
* Shimmick Corporation SHIM.O: Craig-Hallum cuts target price to $4 from $10 |
* Shimmick Corporation SHIM.O: Craig-Hallum cuts to hold from buy |
* Sinclair Inc SBGI.O: Deutsche Bank cuts target price to $16 from $17 |
* SLB SLB.N: zephirin Group raises price objective to $59 from $57 |
* Sphere Entertainment Co SPHR.N: Macquarie cuts target price to $38 from $40 |
* Squarespace Inc SQSP.N: Barclays raises target price to $44 from $40 |
* Squarespace Inc SQSP.N: Citigroup raises target price to $53 from $46 |
* Squarespace Inc SQSP.N: Raymond James cuts to market perform from outperform |
* Squarespace Inc SQSP.N: UBS cuts to neutral from buy |
* Squarespace Inc SQSP.N: UBS cuts to neutral from buy |
* Squarespace Inc SQSP.N: UBS raises target price to $44 from $43 |
* Squarespace Inc SQSP.N: UBS raises target price to $44 from $43 |
* Sun Communities Inc SUI.N: Truist Securities cuts target price to $127 from $136 |
* Talos Energy Inc TALO.N: BMO cuts target price to $14 from $15 |
* Taysha Gene Therapies Inc TSHA.O: Jefferies raises target price to $8 from $2 |
* Taysha Gene Therapies Inc TSHA.O: Jefferies raises to buy from hold |
* Terreno Realty Corp TRNO.N: Jefferies raises target price to $89 from $87 |
* Territorial Bancorp Inc TBNK.O: KBW cuts target price to $9.66 from $10 |
* Transdigm Group Inc TDG.N: Deutsche Bank raises target price to $1435 from $1360 |
* Trex Co Inc TREX.N: JP Morgan raises target price to $95 from $93 |
* Trubridge Inc TBRG.O: Deutsche Bank cuts target price to $11 from $12 |
* Tscan Therapeutics Inc. TCRX.O: Barclays raises target price to $14 from $9 |
* UDR Inc UDR.N: Scotiabank raises target price to $42 from $39 |
* Ulta Beauty Inc ULTA.O: Stifel cuts target price to $475 from $565 |
* United Bankshares Inc UBSI.O: Stephens raises target price to $36 from $34 |
* Valero Energy Corp VLO.N: BMO cuts target price to $182 from $205 |
* Verb Technology Company VERB.O: Ascendiant Capital Markets cuts PT to $4.50 from $5 |
* Verrica Pharmaceuticals Inc VRCA.O: H.C. Wainwright raises PT to $14 from $13 |
* Verrica Pharmaceuticals Inc VRCA.O: Jefferies raises target price to $12 from $10 |
* Verrica Pharmaceuticals Inc VRCA.O: Needham raises target price to $16 from $8 |
* Victory Capital Holdings Inc VCTR.O: RBC raises target price to $56 from $47 |
* Vistra Corp VST.N: RBC raises target price to $105 from $95 |
* Vital Energy Inc VTLE.N: BMO cuts target price to $55 from $63 |
* Vital Energy Inc VTLE.N: Citigroup cuts target price to $60 from $70 |
* Vital Energy Inc VTLE.N: Wells Fargo cuts target price to $54 from $57 |
* Vivid Seats Inc SEAT.O: Deutsche Bank cuts target price to $6.5 from $7 |
* Voyager Therapeutics Inc VYGR.O: Wedbush cuts target price to $8 from $10 |
* Weatherford International Plc WFRD.O: Citigroup initiates coverage With Buy rating |
* Weatherford International Plc WFRD.O: Citigroup initiates coverage With target price $155 |
* Western Digital Corp WDC.O: Citigroup initiates coverage with buy rating; PT $90 |
* Xponential Fitness Inc XPOF.N: Guggenheim cuts target price to $18 from $25 |
(Compiled by Bengaluru Newsroom)
</body></html>Похожие активы
Последние новости
Правовая оговорка: Компании группы XM Group предоставляют только услуги по исполнению сделок и доступ к нашей торговой онлайн-среде, в которой пользователи могут просматривать и (или) пользоваться материалами, доступными на вебсайте либо доступными по ссылкам с данного сайта на другие. Предоставление доступа к онлайн-среде не меняет сути предоставляемых услуг и не расширяет их. Такой доступ и пользование материалами предоставляются с учетом:(i) «Условий и положений»; (ii) «Предупреждений о рисках» и (iii) полного текста «Правовой оговорки». Следовательно, подобные материалы предоставляются лишь в качестве информации общего характера. В частности, просим Вас иметь в виду, что материалы, содержащиеся в нашей торговой онлайн-среде, не являются ни просьбой осуществить какие-либо транзакции на финансовых рынках, ни предложением к осуществлению подобных транзакций. Торговля на любом финансовом рынке подразумевает большой риск потери Вашего капитала.
Все материалы, опубликованные в нашей торговой среде, предоставляются только в образовательных или информационных целях и не содержат (и не должны рассматриваться как содержащие) финансовых, инвестиционных или торговых рекомендаций, а также информации о стоимости наших услуг по предоставлению доступа к рынкам, либо предложения или содействия в проведении транзакций по какому-либо финансовому инструменту или по незапрашиваемым финансовым услугам по отношению к Вам.
Любые материалы на данном вебсайте, созданные третьими лицами, а также материалы, подготовленные XM, такие как мнения экспертов, новости, исследования, анализ, котировки и другая информация, а также ссылки на сторонние сайты предоставляются в виде «как есть», как рыночная информация общего характера, и не являют собой рекомендации по инвестициям. Принимая во внимание то, что любые материалы рассматриваются как инвестиционное исследование, Вам следует учесть и принять тот факт, что никакие материалы не подготавливались и не предназначались к использованию в соответствии с правовыми нормами, способствующими независимости инвестиционных исследований. Следовательно, материалы следует рассматривать как материалы рекламного характера согласно соответствующим законам и правовым нормам. Рекомендуем Вам прочесть и уяснить для себя положения наших «Уведомления о субъективном инвестиционном исследовании» и «Предупреждения о рисках» в отношении приведённой выше информации. С этими документами можно ознакомиться здесь.
